Related references
Note: Only part of the references are listed.Thalamic atrophy and cognition in multiple sclerosis
M. K. Houtchens et al.
NEUROLOGY (2007)
Interferon beta-1 a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy
R. Zivadinov et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies
MP Amato et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
MRI T2 lesion burden in multiple sclerosis - A plateauing relationship with clinical disability
DKB Li et al.
NEUROLOGY (2006)
Magnetic resonance imaging measures of brain atrophy in multiple sclerosis
VM Anderson et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2006)
Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS
K Morgen et al.
NEUROIMAGE (2006)
Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis
MP Sanfilipo et al.
NEUROLOGY (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Cortical demyelination and diffuse white matter injury in multiple sclerosis
A Kutzelnigg et al.
BRAIN (2005)
Long-term clinical outcome of primary progressive MS:: Predictive value of clinical and MRI data
J Sastre-Garriga et al.
NEUROLOGY (2005)
Brain atrophy and lesion load in a large population of patients with multiple sclerosis
G Tedeschi et al.
NEUROLOGY (2005)
The relationship between whole brain volume and disability in multiple sclerosis: A comparison of normalized gray vs. white matter with misclassification correction
MP Sanfilipo et al.
NEUROIMAGE (2005)
Gray and white matter volume changes in early RRMS - A 2-year longitudinal study
M Tiberio et al.
NEUROLOGY (2005)
Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes
CM Dalton et al.
BRAIN (2004)
Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite
J Hobart et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial
M Filippi et al.
LANCET (2004)
Grey and white matter atropy in early clinical stages of primary progressive multiple sclerosis
J Sastre-Garriga et al.
NEUROIMAGE (2004)
Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis
DT Chard et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
A semiautomated measure of whole-brain atrophy in multiple sclerosis
RA Bermel et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Evidence of early cortical atrophy in MS relevance to white matter changes and disability
N De Stefano et al.
NEUROLOGY (2003)
The relationship of brain and cervical cord volume to disability in clinical subtypes of multiple sclerosis: a three-dimensional MRI study
X Lin et al.
ACTA NEUROLOGICA SCANDINAVICA (2003)
Eight-year follow-up study of brain atrophy in patients with MS
E Fisher et al.
NEUROLOGY (2002)
Accurate, robust, and automated longitudinal and cross-sectional brain change analysis
SM Smith et al.
NEUROIMAGE (2002)
Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy
VL Stevenson et al.
JOURNAL OF NEUROLOGY (2002)
Optimizing the association between disability and biological markers in MS
NF Kalkers et al.
NEUROLOGY (2001)
Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions
JW Peterson et al.
ANNALS OF NEUROLOGY (2001)
The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis
PD Molyneux et al.
BRAIN (2000)
Share Paper
